Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
FFunPep Company Limited logo
4881TSE Growth

FunPep Company Limited

ファンペップ Yahoo Finance

Recent & upcoming events

Aug 14
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 12
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 25
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Feb 12
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 13
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
2027
Feb 5
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 7
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Aug 6
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥314,000 YoY -94.9%
Operating income ¥-1.65B margin -525053.5%
Net income ¥-1.91B YoY —
EPS ¥-50 YoY —
P/E —
ROE —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ¥0¥0¥414,000¥116,000——
Operating income ¥-183M¥-188M¥-184M¥-212M——
Net income ¥-161M¥-187M¥-169M¥-211M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

事業法人 10.1%国内機関 10.6%個人 4.4%未開示 73.2%202020212022202320242025
創業家事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

塩野義製薬株式会社 6.6%塩野義製薬株式会社楽天証券株式会社 3.5%楽天証券株式会社SBI4&5投資事業有限責任 2.9%SBI4&5投資事業有限責任組合三好　稔美 2.8%三好　稔美株式会社ＳＢＩ証券 2.2%株式会社ＳＢＩ証券株式会社ReBeage 2%株式会社ReBeageNew Life Science１号 2%New Life Science１号投資事業有限責任組合有限会社アドバンステクノロジー 1.7%有限会社アドバンステクノロジー吉田　克己 1.6%吉田　克己株式会社メディパルホールディングス 1.5%株式会社メディパルホールディングス202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
塩野義製薬株式会社 2,682,500 6.6% Yuho (EDINET)
楽天証券株式会社 1,428,900 3.5% Yuho (EDINET)
SBI4&5投資事業有限責任組合 1,190,400 2.9% Yuho (EDINET)
三好 稔美 1,125,000 2.8% Yuho (EDINET)
株式会社SBI証券 903,998 2.2% Yuho (EDINET)
株式会社ReBeage 800,000 2.0% Yuho (EDINET)
New Life Science1号投資事業有限責任組合 793,600 2.0% Yuho (EDINET)
有限会社アドバンステクノロジー 700,000 1.7% Yuho (EDINET)
吉田 克己 648,600 1.6% Yuho (EDINET)
株式会社メディパルホールディングス 595,200 1.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

1/9 1 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -96.5%
✗ Positive operating cash flow ¥-1.39B
✗ ROA improved YoY -28.6% → -96.5%
✓ Operating CF exceeds net income (accrual quality) OCF ¥-1.39B / net income ¥-1.91B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 81.6% → 72.7%
✗ Current ratio improved 5.75× → 3.74×
✗ No dilution (shares outstanding did not increase) 32,408,800 → 40,563,800
— Gross margin improved No data
✗ Asset turnover improved 0.00× → 0.00×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 72.7%
Current ratio 3.7×
Years of positive operating CF 0 of last 5 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss ¥1.91B)

Performance history

Last 10 years
0億円0億円1億円1億円1億円 FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
Revenue 0.031.270.010.010.060.00
Operating income -5.65-7.45-11.7-9.94-9.02-16.5
Ordinary income -5.05-6.80-11.8-9.40-8.96-16.3
Net income -5.08-6.82-11.7-9.33-8.89-19.1
Total assets 37.233.629.924.931.119.8
Equity 35.731.826.923.025.514.6

Indicators & cash flow

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
EPS ¥-40¥-40¥-61¥-40¥-32¥-50
ROE ——————
Operating CF -4.98—-10.5-9.89-5.37-13.9
Investing CF ——-0.19-0.01-0.31-0.01
Financing CF 31.4—2.455.3811.28.11
FCF -4.14—-10.7-9.90-5.68-13.9

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data